Liabilities / Assets
36th percentile
Higher debt load relative to assets than 36% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
36th percentile
Higher debt load relative to assets than 36% of similar nonprofits.
Liabilities / Revenue
47th percentile
Higher debt load relative to revenue than 47% of similar nonprofits.
Net Margin
97th percentile
Higher net margin than 97% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
97th percentile
Faster asset growth than 97% of similar nonprofits.
Revenue Growth
96th percentile
Faster revenue growth than 96% of similar nonprofits.
Assets
Up$9,253,046
Up $4,634,378 (+100%) from 2012
Net Assets
Up$8,404,835
Up $4,382,323 (+109%) from 2012
Liabilities
Up$848,211
Up $252,055 (+42%) from 2012
Revenue
Up$5,128,500
Up $3,411,760 (+199%) from 2012
Expenses
Up$762,375
Up $405,375 (+114%) from 2012
Net Income
Up$4,366,125
Up $3,006,385 (+221%) from 2012
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Charley's fund's singular mission is to support the development of treatments and a cure for duchenne muscular dystrophy (dmd). We identify and direct funding to the most compelling research and treatment programs related to dmd and, (cont. On sch. O.)
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.